| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/000456327601300101 |
| P953 | full work available at URL | http://journals.sagepub.com/doi/pdf/10.1177/000456327601300101 |
| P698 | PubMed publication ID | 56153 |
| P2093 | author name string | A. M. Neville | |
| E. H. Cooper | |||
| P2860 | cites work | Cancer Research | Q326097 |
| Lymphocyte sensitisation: an in-vitro test for cancer? | Q93694128 | ||
| Cancer, immunological surveillance, and 2 -globulin | Q93728923 | ||
| Carcinoembryonic antigen (CEA): demonstration of a partial identity between CEA and a normal glycoprotein | Q93730060 | ||
| Alpha fetoprotein in maternal serum: a new marker for detection of fetal distress and intrauterine death | Q93730484 | ||
| Blood carcinoembryonic antigen, Regan isoenzyme, and human chorionic gonadotrophin in primary mediastinal carcinoma | Q93732069 | ||
| The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system | Q33817676 | ||
| Ectopic production of the isolated beta subunit of human chorionic gonadotropin | Q34515618 | ||
| Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen | Q34727061 | ||
| Subunits of Human Chorionic Gonadotropin: Unbalanced Synthesis and Secretion by Clonal Cell Strains Derived from a Bronchogenic Carcinoma | Q35103632 | ||
| Excretion of hydroxyproline in patients with rheumatic and non-rheumatic diseases | Q35559193 | ||
| Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review | Q36039439 | ||
| The frequency of M-components in sera of patients with solid malignant neoplasms | Q36039881 | ||
| Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease | Q36040001 | ||
| Immunological study of carcinoembryonic antigen (CEA) and a related glycoprotein | Q36040209 | ||
| The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer | Q36040241 | ||
| The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer | Q36041475 | ||
| Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal | Q36041539 | ||
| Specific carcinoembryonic antigens of the human digestive system | Q36267788 | ||
| Enzyme activity in invasive tumors of human breast and colon | Q37443772 | ||
| Ectopic production of human chorionic gonadotropin in Ugandan patients with hepatocellular carcinoma | Q38894717 | ||
| Urinary polyamine levels in human cancer | Q39313916 | ||
| Correlation of the blood-level of a pregnancy-associated alpha-macroglobulin with the clinical course of cancer patients | Q39324238 | ||
| Letter: Comparison of plasma carcinoembryonic antigen and alpha-fetoprotein in various tumours | Q39342776 | ||
| Report of the workshop on the carcinoembryonic antigen (cea): the present position and proposals for future investigation | Q39872231 | ||
| Plasma protein measurements as a diagnostic aid. | Q39888167 | ||
| Ectopic hormone production by non-endocrine tumours | Q39901291 | ||
| Rapid radioimmunoassay of carcinoembryonic antigen (CEA) in ultrafiltered perchloric acid extracts: Results of a clinical survey | Q39918038 | ||
| Cancer, Differentiation and Embryonic Antigens: Some Central Problems | Q39944312 | ||
| Glycosyltransferases in human blood. II. Study of serum galactosyltransferase and N-acetylgalactosaminyltransferase in patients with liver diseases | Q40326346 | ||
| Demonstration of sensitized lymphocytes in blood | Q41253180 | ||
| Combination of carcinoembryonic antigen and gamma glutamyl transpeptidase in the study of the evolution of colorectal cancer | Q41451029 | ||
| Carcinoembryonic antigen-like substances of human urothelial carcinomas. Isolation of components from pathological urine and comparison with colorectal carcinoma antigens | Q42562087 | ||
| Measurement of Prolactin Activity in Human Serum by the Induction of Specific Milk Proteins in Mammary Glandin Vitro | Q43452322 | ||
| Ectopic gonadotropin production before clinical recognition of bronchogenic carcinoma | Q43488179 | ||
| Biological markers in breast carcinoma.I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides | Q43581662 | ||
| Serum fucose in the diagnosis of breast cancer | Q43917967 | ||
| Immunological studies of membrane glycoproteins isolated from human breast carcinomas | Q44761400 | ||
| Prognostic factors in colon carcinoma: correlation of serum carcinoembryonic antigen level and tumor histopathology | Q44998010 | ||
| Serum alpha-feto-protein and primary cancer of the liver in man. | Q46410736 | ||
| Serum alpha-feto-protein. VII. The range of apparent serum values in normal people, pregnant women, and primary liver cancer high risk populations | Q46810634 | ||
| Carcinoembryonic antigen by radioimmunoassay in the detection of recurrence during long-term followup of female genital cancer | Q47844489 | ||
| Ectopic production of the isolated alpha subunit of the glycoprotein hormones. A quantitative marker in certain cases of cancer | Q47865429 | ||
| Brief Communication: Carcinoembryonic Antigen and Alpha-Fetoprotein in the Diagnosis of Gastric and Colonic Cancer: A Comparative Clinical Evaluation2 | Q47872808 | ||
| Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress | Q47876977 | ||
| Carcinoembryonic antigen: Clinical correlation with chemotherapy for metastatic gastrointestinal cancer | Q47876985 | ||
| Relationship of ectopic placental alkaline phosphatase to ectopic chorionic gonadotropin and placental lactogen.Discordance of three “markers” for cancer | Q47886679 | ||
| Studies on carcinoembryonic antigen (CEA) and a related glycoprotein, CCEA-2. Preparation and chemical characterisation | Q47930774 | ||
| Biochemical parameters correlated with tumour cell implantation | Q47936899 | ||
| Evaluation of carcinoembryonic antigen in human mammary carcinoma | Q47953773 | ||
| Ectopic Production of Human Chorionic Gonadotrophin by Neoplasms | Q47970603 | ||
| Serum β2-microglobulin in various disorders | Q48013249 | ||
| Polymorphism of protein and polypeptide hormones | Q48032424 | ||
| Increased polyamine concentrations in the cerebrospinal fluid of patients with brain tumors | Q48498333 | ||
| Do generalized metastases occur directly from the primary? | Q52881844 | ||
| Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (C.E.A.). | Q53727963 | ||
| Beta2-microglobulin: occurrence in fetal life and malignancy. | Q53741789 | ||
| [Presence of a ferroprotein of tissue origin, the alpha-2H globulin, in sera of children with tumors]. | Q53761855 | ||
| Urinary Excretion by Cancer Patients of the Nucleosides N 2 , N 2 -Dimethylguanosine, 1-Methylinosine, and Pseudouridine 2 | Q53851915 | ||
| Ectopic production of an alkaline phosphatase isoenzyme in patients with cancer. | Q54353112 | ||
| Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas. | Q54483364 | ||
| Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. | Q54619260 | ||
| Carcinoembryonic Antigen in the Urine of Patients with Urothelial Carcinoma | Q55436019 | ||
| Extreme elevation of serum transcobalamin I in patients with metastatic cancer | Q66840522 | ||
| CEA as a monitor of gastrointestinal malignancy | Q66908764 | ||
| Carcinoembryonic Antigen and Prognosis in Patients with Colon Cancer | Q66915967 | ||
| Hydroxyproline excretion in patients with breast cancer and response to treatment | Q66921949 | ||
| Aspirin inhibition of in vitro osteolysis stimulated by parathyroid hormone and PGE1 | Q67255508 | ||
| Placental proteins and their subunits as tumor markers | Q67503051 | ||
| Hypercalcaemia of neoplasia, parathyroid hormone and vitamin D: studies in parabiosis | Q68697567 | ||
| Seromucoid in serum in benign and malignant gynaecological disorders | Q68775343 | ||
| Carcinoembryonic antigen in management of colorectal carcinoma | Q68807669 | ||
| Radio-immunoassay of casein in the serum of normal subjects and of patients with various malignancies | Q68919865 | ||
| An immunoassay for pregnancy-associated α-macroglobulin using antibody-enzyme conjugates | Q68927039 | ||
| Leukocyte adenosine deaminase phenotypes in acute leukemia | Q68993935 | ||
| Carcinoembryonic Antigen in Cancer of the Female Reproductive System Sequential Levels and Effects of Treatment* | Q69022660 | ||
| Evidence for Control of Several Different Tissue-specific Isozymes of Adenosine Deaminase by a le Genetic Locus | Q69033493 | ||
| The prognostic significance of serial seromucoid analyses in patients with cancer | Q69355834 | ||
| Regan isoenzyme in patients with hematopoietic tumors | Q69357367 | ||
| On improving the diagnostic value of quantitative medical laboratory tests in conventional practice | Q69406540 | ||
| Nonparathyroid Humoral Hypercalcemia in Patients with Neoplastic Diseases | Q69540116 | ||
| Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease | Q69771320 | ||
| Serum alpha fetoprotein concentration and tumor growth dissociation in a patient with ovarian teratocarcinoma | Q69997683 | ||
| Early termination of anencephalic pregnancy after detection by raised alpha-fetoprotein levels | Q69998373 | ||
| Raised alpha-fetoprotein in maternal serum with anencephalic pregnancy | Q69999222 | ||
| Transplantation--nature's success | Q70000240 | ||
| Amniotic-fluid alpha-fetoprotein in the antenatal diagnosis of spina bifida | Q70000313 | ||
| Prenatal diagnosis of anencephaly through maternal serum-alphafetoprotein measurement | Q70001982 | ||
| Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours | Q70019756 | ||
| Radioimmune assay of carcinoembryonic antigen | Q70394634 | ||
| Role of Plasma Carcinoembryonic Antigen in Diagnosis of Gastrointestinal, Mammary, and Bronchial Carcinoma | Q70478068 | ||
| New observations on the Regan isoenzyme of alkaline phosphatase in cancer patients | Q70518740 | ||
| Demonstration of an Antigen Common to Several Varieties of Neoplasia | Q70560854 | ||
| The biochemical role of naturally occurring polyamines in nucleic acid synthesis | Q71138264 | ||
| Urinary purines and pyrimidines in normal and leukemic subjects | Q72091134 | ||
| Urinary hydroxyproline excretion in patients with cancer | Q72416959 | ||
| Studies on 5-ribosyluracil in man | Q72818448 | ||
| A study of serum glycoproteins in cancer | Q74540492 | ||
| Factors leading to elevations in serum acid glycerophosphatase | Q75985488 | ||
| HYDROXYPROLINE IN THE SERUM AND URINE OF PATIENTS WITH HYPERTHYROIDISM | Q76734276 | ||
| Purine and pyrimidine excretion in normal and leukemic subjects | Q79129830 | ||
| Additional components in ribonucleic acid of rat-liver fractions | Q79220493 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 283-305 | |
| P577 | publication date | 1976-01-01 | |
| P1433 | published in | Annals of Clinical Biochemistry | Q15716536 |
| P1476 | title | Biochemical Monitoring of Cancer: A Review | |
| Biochemical monitoring of cancer. A review | |||
| P478 | volume | 13 |
| Q40282167 | 'End-points in cancer therapy' the Glyn Evans memorial lecture of the Royal College of Radiologists |
| Q39207752 | 3 Clinical biochemistry of alcoholism |
| Q44969678 | A biochemical approach to the staging of human breast cancer |
| Q39576337 | Acute Phase Reactant Proteins in Cancer |
| Q41727515 | Acute Phase Reactant Proteins in the Clinical Management of Carcinoma of the Bladder |
| Q39465435 | Acute phase reactant proteins in prostatic cancer |
| Q36069023 | Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes |
| Q39180403 | Biochemical Aids to Cancer Management |
| Q37868813 | Biochemical markers in bronchogenic carcinoma |
| Q39418728 | Biochemical markers in human breast cancer |
| Q34983081 | Biochemical profiles in tumour monitoring and their analysis |
| Q72098300 | C1q binding activity in the sera of patients with chronic lung diseases |
| Q40077420 | Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line |
| Q39240061 | Cancer markers in patients receiving chemotherapy for colorectal cancer: A preliminary report |
| Q72650760 | Cancer serum index: A useful nonspecific test as a parameter in multimodality screening and assessment of patients with cancer of the prostate |
| Q36610231 | Cancer-associated proteins in effusion fluids |
| Q40953761 | Carcinoembryonic antigen and other tumor markers in tissue and serum or plasma of patients with primary mammary carcinoma |
| Q36043588 | Carcinoembryonic antigen in endoscopic brush specimens from benign and malignant gastric lesions |
| Q40165576 | Carcinoembryonic antigens and related glycoproteins molecular aspects and specificity |
| Q70213086 | Cell membrane, but not circulating, carcinoembryonic antigen is linked to a phosphatidylinositol-containing hydrophobic domain |
| Q72662524 | Changes in serum acute phase proteins in breast cancer patients receiving methotrexate infusion therapy |
| Q39752478 | Chemotherapy and Chemoimmunotherapy of Colorectal Cancer: Role of the Carcinoembryonic Antigen |
| Q34986252 | Clinical applications of serum carcinoembryonic antigen and alpha-fetoprotein levels in children with solid tumours |
| Q36604570 | Clinicopathological role of tumour index substances in paediatric neoplasia |
| Q72503236 | Comparative study of gamma glutamyl transferase, alkaline phosphatase and its αl isoenzyme as biological indicators of liver metastases |
| Q40210029 | Cost effectiveness of postoperative carcinoembryonic antigen monitoring in colorectal cancer |
| Q37259274 | Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2 |
| Q37508622 | Follow-up plans after treatment of primary colon and rectum cancer |
| Q39525474 | Increased alpha-fetoprotein concentration in association with ileal adenocarcinoma complicating Crohn's disease |
| Q39627633 | Influence of specialty affiliation on physicians' pattern of use of CEA test |
| Q41147101 | Mapping epitope characteristics on carcinoembryonic antigen |
| Q41651627 | Multiparametric Markers in the Monitoring of Cancer |
| Q72908298 | Multiple biologic markers in the monitoring of treatment for patients with small cell carcinoma of the lung: The use of serial levels of plasma cea and serum carbohydrates |
| Q73003592 | Pre-operative plasma levels of C-reactive protein, albumin and various plasma protease inhibitors for the pre-operative assessment of operability and recurrence in cancer surgery |
| Q66981806 | Predictive value of plasma CEA in patients with colorectal carcinoma |
| Q44898773 | Products of gynaecological neoplasms: Clinical and pathological applications |
| Q34473241 | Progress report. Cancer of the pancreas |
| Q39546012 | Recent Advances in the Immunodiagnosis of Cancer |
| Q71697488 | Routine compared with nonscheduled follow-up of patients with "curative" surgery for colorectal cancer |
| Q36042191 | Serum biochemical markers in lung cancer |
| Q36046860 | Serum levels of human placental lactogen and pregnancy-specific beta 1-glycoprotein in breast cancer |
| Q40107440 | Short-Term Tests with Biochemical End Points Relevant to the Prediction of Carcinogenic Potential of Drugs |
| Q70937626 | Significance of serum concentrations of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer |
| Q39569818 | Structural and antigenic properties of carcinoembryonic antigen (CEA) |
| Q34246012 | Structural, Functional, and Clinical Aspects of γ-Glutamyltransferase |
| Q41916052 | The clinical diagnostic value of the carcinoembryonic antigen (CEA) in haematuria |
| Q40250883 | The deduction of tumor histogenesis, with special reference to teratomas and ovarian tumors |
| Q71351238 | The diagnostic value of plasma carcinoembryonic antigen (CEA) in pancreatic disease. Medical Research Council Tumour Products Committee: Clinical Subgroup |
| Q39557832 | The early effects of chemical carcinogens on adult rat hepatocytes in primary culture. II. Effects on unscheduled DNA synthesis, cell division and α-fetoprotein production |
| Q44993686 | The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinoma |
| Q93594448 | The presence of glycosylated, biologically active chorionic gonadotropin in human liver |
| Q72656467 | The serum levels of human α− fetoprotein, AFP, choriogonadotropin, hCG, placental lactogen, hPL, and pregnancy-specific β1-glycoprotein, SP1, are of no clinical significance in colorectal carcinoma |
| Q36466896 | The value of tumour markers in lung cancer |
| Q49275882 | The value of urinary polyamine assay in stomach cancer. Comparison with serum carcinoembryonic antigen |
| Q39849126 | Towards selectivity in cancer chemotherapy: A biochemical overview |
| Q39561773 | Tumour markers in urology: Aids in cancer diagnosis and management |
| Q67652294 | Tumour-associated antigens: still too fickle for population screening |
| Q66696883 | Ubiquitous human chorionic gonadotrophin? |
| Q63977984 | Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer |
| Q40242867 | Usefulness of clinical chemistry measurements in classifying patients with breast cancer |
Search more.